BTU Metals Corp (CVE:BTU) (OTCMKTS:BTUMF) said Tuesday that a new litho-structural report on its Dixie Halo property in Ontario identified “numerous” new gold exploration targets. The geological report outlined 14 target areas that warrant follow up, with nearly half of the targets deemed high priority, the Vancouver-based explorer told shareholders. Dixie Halo, a 200-square-kilometre property in Red Lake, is adjacent to the high-grade Dixie gold project owned by Great Bear Resources (CVE:GBR). The report confirmed that the prolific LP Fault that runs through Dixie extends toward the northeast corner of the main block of the Dixie Halo property.
Vuzix Corporation (NASDAQ:VUZI) has partnered with the Children of War Foundation to further the access to medical and surgical education utilizing Vuzix M400 Smart Glasses to connect healthcare professionals and surgeons serving disadvantaged populations in coordination with US-based academic hospital institutions.In light of the COVID-19 pandemic, much of the Children of War Foundation's ability to physically mobilize medical teams has slowed down due to travel restrictions, the company noted. However, with the use of advanced smart glass technology and connectivity, the foundation is expanding its reach more than ever before, connecting team members to its network anytime, anywhere, thanks to Vuzix M400 Smart Glasses.
Bioasis Technologies Inc (CVE:BTI) (OTCQB:BIOAF) announced Tuesday that the US Patent and Trademark Office (USPTO) issued a patent for the company’s xB3 platform technology, which is designed to deliver therapeutics across the blood-brain barrier (BBB). The xB3 method utilizes Bioasis’ novel platform technology to administer a broad array of therapeutic agents to the brain tissue in patients who can benefit from this targeted delivery, the company said, such as those with lysosomal storage diseases. “We are excited about the issuance of this patent by the US Patent Office because it represents a major milestone for our intellectual property protection around our core assets,” CEO Deborah Rathjen said in a statement. “Adding to the already granted patents in the U.S. and around the world, this further strengthens and reinforces our standing around our core technology and our xB3 programs.”
Cabral Gold Inc (CVE:CBR) (OTCPINK:CBGZF) announced Tuesday that it has identified a new high-grade target called Dona Moca at its Cuiú Cuiú gold project in northern Brazil. Dona Moca is located 1.6 kilometres east northeast of the company’s Medusa target. Surface grab samples returned gold values of 108.3 grams per ton (g/t), 32.0 g/t, 21.9 g/t and 3.9 g/t in surface cobbles. Cabral also revealed that soil sampling at the Medusa target has identified a large coherent gold-in-soil anomaly which extends at least 1.4 km and has a pronounced east southeast trend, extending east of the previously reported high-grade boulders which range from 1.1 g/t to 82.2 g/t of gold.
Klondike Gold Corp (CVE:KG) (OTC:KDKGF) announced Tuesday that it has closed the second tranche of its C$3.8 million non-brokered private placement to fund continued exploration and development of its Yukon properties. In the second trance, the company issued 6.1 million flow-through units, each containing one flow-through share and one half warrant, at a price of C$0.30 per unit. It also issued 1.5 million non-flow-through units at a price of C$0.25 per unit.
Water Tower Research has issued three new analyst notes by equity research veteran Dr John Roy, who recently joined the firm as Managing Director – IT Hardware. The notes are on Infinera (NASDAQ: INFN) https://wp-wtr-2020.s3.eu-west-2.amazonaws.com/media/2020/10/18162727/INFN_IOC_Brief_v5-UpChrt.pdf; Extreme Networks (NASDAQ:EXTR) https://wp-wtr-2020.s3.eu-west-2.amazonaws.com/media/2020/10/18162725/EXTR_IOC_Brief_v5-UpChrt.pdf; and Cisco Systems (NASDAQ: CSCO) https://wp-wtr-2020.s3.eu-west-2.amazonaws.com/media/2020/10/18162723/CSCO_IOC_Brief_v6-UpChrt.pdf Separately, Shawn Severson who is the head of Sustainable Investing and BioEconomy Research at Water Tower Research has initiated coverage on Blink Charging Co (NASDAQ:BLINK) riding high on growing electric vehicle sales.
Chesapeake Financial Shares Inc (OTCQX:CPKF), which operates as the bank holding company for Chesapeake Bank, reported Tuesday third-quarter earnings of $3.38 million, a 4.8% year-over-year increase. In a statement, the company said earnings per share were $0.692 fully diluted, compared to $0.649 fully diluted for the third quarter of 2019. Total assets ended the quarter at $1.17 billion, a 24.2% increase since September 30.
Cardiol Therapeutics Inc (TSE:CRDL) (OTCQX:CRTPF) said Tuesday that its THC-free oral CBD formulation Cortalex is now available online through Shoppers Drug Mart’s Medical Cannabis by Shoppers portal. In a statement, the biotechnology company said there was “growing demand” from paediatricians and family physicians for a THC-free CBD formulation, but most CBD formulations currently available in Canada contain potentially psychoactive levels of THC and cannot be used by certain patient populations. Cortalex is the first pharmaceutically-produced CBD oil that is specifically formulated for patients who would benefit from the therapeutic effects of cannabidiol but should not take THC, such as children and young adults or seniors with chronic diseases.
Mackie Research Capital has initiated coverage of FansUnite Entertainment Inc. (CSE:FANS) (OTCMKTS:FUNFF) with a 'Speculative Buy' recommendation and a target price of $0.55 per share. In a note to clients, the Mackie analysts noted that potential catalysts for the stock include an expansion of B2B contracts and B2C platforms, the award of new licenses, revenue growth and M&A activity.
Todos Medical Ltd. (OTCQB:TOMDF) announced that it has received a notice of allowance from the European Patent Office covering the use of the company’s Total Biochemical Infrared Analysis (TBIA) platform to detect benign colon cancer in peripheral blood. The TBIA platform uses spectroscopy-based infrared analysis method to analyze immune cells in the blood or order to turn the biological information in the blood into data, and then mines that data using artificial intelligence to develop algorithms that are predictive of cancer and other diseases that impact the immune system, including bacteria and viruses. TBIA’s lead programs are in the detection of breast cancer and colon cancer.
Lucky Minerals Inc (CVE:LKY) (OTCMKTS:LKMNF) has outlined a large alteration area measuring around 2.8 kilometres by 2 kilometres at its Fortuna 4 concession in southern Ecuador. The so-called Emma prospect lies around 8 kilometres south of the El Garo prospect and the firm said results from rock chip samples had confirmed anomalous gold."The outlined surface alteration at Emma is an exciting prospect identified by our field team in September," Francois Perron, who was appointed the new chief executive (CEO) of Lucky Minerals in September, said in a statement. "Thanks to the diligent work of the team by following strict COVID-19 health & safety protocols and local regulations, work has continued throughout the month of September and into October," he added.
GGX Gold Corp. (CVE:GGX) (OTCQB:GGXXF) (FRA:3SR2) has provided an update on its active exploration program at the Gold Drop property in the Greenwood Mining Camp of south-central British Columbia. The group said the planned drilling program at the property is well underway with 1,834.5 meters (m) being completed in 11 holes. The first diamond drill hole was completed at a depth 786.1m (2579 feet) to test the airborne geophysical anomaly that was identified by Earth Science Services Corporation of Oshawa, Ontario (ESSCO).
The Flowr Corporation (CVE:FLWR) (OTCMKTS:FLWPF) announced that it has entered into a definitive agreement to acquire all the shares in Terrace Global Inc (CVE:TRCE), a multi-country operator (MCO) led by experienced cannabis entrepreneurs focused on the acquisition of international cannabis assets. The all-share acquisition is valued at around $63 million based on Flowr’s closing share price on October 19, 2020. The transaction provides the company with additional capital to execute on its growth strategy, and seeks to merge together two teams of successful cannabis entrepreneurs, said the company. The transaction is expected to close by the end of 2020. The acquisition significantly bolsters Flowr’s balance sheet with more than $31 million in cash and marketable securities to support growth.
1933 Industries Inc (CSE:TGIF) (OTCQX:TGIFF) said Tuesday it is partnering with Orchid Ventures Inc (CSE: ORCD) (OTCMKTS:ORVRF) to manufacture and distribute Orchid products in the Nevada cannabis market. The supply and licensing agreement was struck between Washington-based Orchid Ventures’ subsidiary Orchid Brands, LLC and 1933 Industries’ subsidiary Alternative Medicine Association LLC. Both companies will leverage AMA's extraction expertise and well-established sales and distribution channels in the state, 1933 Industries said. Under the three-year agreement, 1933 Industries said it will purchase Orchid's PurTec hardware and packaging component products and proprietary terpene blends required for the production of Orchid Essentials products. AMA will act as the exclusive supplier of the Orchid Essentials Brand Products and future lines, and will also purchase the same hardware components, packaging, and terpenes for its own branded products.
KWESST Micro Systems Inc (CVE:KWE) announced Tuesday the elevation of its affiliation with SAMSUNG Electronics America Inc to "USA Partner" status. As a SAMSUNG USA Partner, KWESST said it will be employing the SAMSUNG S20TE tactical smartphone in the production version of its Tactical Awareness and Situational Control System (TASCS) and for its Integrated Fires Module (IFM) for networked targeting on soldiers' weapons. "SAMSUNG tactical smart devices are the preferred choice of military users around the world," said Jeff MacLeod, KWESST founder and CEO. "Therefore KWESST's new status as a SAMSUNG USA Partner further positions KWESST to advantage in the tactical ecosystem." In other company news Tuesday, David Luxton, executive chairman of KWESST, celebrated the company's new listing on TSX Venture Exchange and open the market.
Mawson Gold Ltd (TSE:MAW) (OTCPINK:MWSNF) (FRA:MXR) told investors it had kicked off drilling at the Mount Isa block in Queensland, Australia and applied to increase its large ground position in the area. The Queensland government has provided a grant of A$200,000, which will fully fund one 800 metres (m) long drill hole to test a large undrilled gravity anomaly, called the F11 target. F11 lies laterally from the so-called Cloncurry fault, a significant regional structure, which in itself is near the Cannington silver-lead mine owned by South32 Ltd - the ninth-largest silver producer in the world with 12.3 million ounces (Moz) produced last year.
CytoDyn Inc.(OTCQB:CYDY), a biotechnology company developing leronlimab (PRO 140) for multiple indications, revealed on Tuesday that the Data Safety Monitoring Committee (DSMC) had issued a positive interim analysis of leronlimab in the Phase 2b/3 registrational trial in patients with severe-to-critical coronavirus (COVID-19). The Vancouver, Washington-based company said the interim analysis was performed on data from the first 195 (50%) of 390 planned patients.
Benchmark Metals Inc (CVE:BNCH) (OTCQX:BNCHF) continues to report good drill results from the flagship Lawyers project in British Columbia, which show the potential to expand the resource. The latest assays hail from the AGB zone of the project, where broad zones, including 41.94 metres (m) of 1.49 grams per tonne (g/t) gold and 106.84 g/t silver or 2.82 g/t gold equivalent (AuEq), were encountered. So far this year, 61 holes for 11,863 metres have been completed at AGB and gold-silver mineralization has been expanded to the west and shows a more than 600-metre strike length.
Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery, shared the promising results of an experimental study with its investigational new drug ARDS-003 in a model of lung injury. The Canadian biopharmaceutical company said it has completed pre-clinical studies demonstrating the anti-inflammatory effect of ARDS-003, in an animal model of lung injury known as "induced pulmonary fibrosis" (IPF). This occurs when lung tissue is scarred, often as a result of extreme or prolonged inflammation, and results in a stiffening of lung tissue that may lead to respiratory problems and, in extreme cases, respiratory failure. While human conditions associated with lung injury may be caused by autoimmune disorders or viral infections, application of inflammatory agents such as bleomycin has been shown to induce similar effects in animal models. The company said its potential coronavirus therapy ARDS-003 reduced the levels of key inflammatory cytokine markers.
African Gold Group Inc (CVE:AGG) revealed new drill results on Tuesday that confirmed gold mineralization along the Gosso shear zone at the Kobada gold project in Mali. Diamond drilling at Gosso showed a highly mineralized gold ore body with similar characteristics to the parallel Kobada shear zone, which boasts a total resource of 2.3 million ounces over a four-kilometre strike length.
Revive Therapeutics Ltd (CSE:RVV) (OTCMKTS:RVVTF) (FRA:31R) has signed a supply agreement with Havn Life Sciences Inc. (CSE:HAVN) (FRA:5NP) to source naturally derived psychedelic compounds such as psilocybin for use in future investigational new drug (IND) enabling studies and clinical trials under US Food and Drug Administration guidelines. "We are excited about our strategic partnership with Havn Life as one of our suppliers of psychoactive compounds that we intend to develop and commercialize using our established tannin-chitosan based proprietary oral-thin film delivery system, for the pharmaceutical and wellness markets,” said Revive CEO Michael Frank in a statement Tuesday. “We are developing unique products with both synthetic and naturally-derived psilocybin and building relationships with companies and institutions that support our objectives in the psychedelic space including our established relationship with the University of Wisconsin-Madison in the research and clinical development of our novel Psilocybin oral-thin film product and the Phase 1 clinical study using psilocybin in the treatment of methamphetamine use disorder.”
HealthLynked Corp (OTCQB:HLYK) announced on Tuesday that through a cash-and-stock deal, it has acquired MedOfficeDirect LLC (MOD), a Naples, Florida-based virtual distributor of discounted medical supplies to both consumers and medical practices. The acquisition, costing up to $6 million, includes $2.7 million of HealthLynked stock issued at the closing of the deal, $0.7 million in cash, and up to $2.6 million of additional HealthLynked common stock, based on MOD achieving specific annual revenue milestones for the next four years, said the company. According to the company, the new acquisition is expected to contribute around $1.5 million of revenue in year one, increasing HealthLynked's consolidated revenues by some 25%.
Exro Technologies Inc. (CVE:EXRO) (OTCQB:EXROF) has announced that it is opening the doors to the newly established Calgary Innovation Center, a major milestone for Exro in its path to delivering commercial products. The leading technology company, which has developed a new class of power electronics for electric motors and powertrains, said the new facility will allow in-house design, testing, and assembly of manufactured products to enhance the performance of electric motors and powertrains. The test equipment will feature small and large test bays that will demonstrate the patented technology in relevant environments and accelerate prototypes in operating applications, it added.
Media Central Corporation Inc (CSE:FLYY) (FRA:3AT) has expanded its existing partnership with iMD Health Global (iMD) to provide readers of NOW Magazine, the Georgia Straight and Canncentral.com with up-to-date health information. New co-branded spaces in partnership with iMD appeared in NOW starting October 8 and will soon be implemented on the Straight and Canncentral platforms, the company said. These areas are designed to give health brands the opportunity to offer expert insight through branded content.
NexTech AR Solutions Corp (OTCQB:NEXCF) (CSE:NTAR) (FRA:N29) announced Tuesday that its InfernoAR platform has been selected by Enterprise Florida Inc for the first-ever virtual Florida International Trade Expo, to be held on March 16-18, 2021. Enterprise Florida is a public-private partnership between business and government leaders and is the principal economic development organization for the state. The contract with NexTech has an initial value of $200,000 over a span of 12 months.
Viscount Mining Corp (CVE:VML) (OTCQB:VLMGF) (FRA:7VM) told investors it had increased its ground at the Cherry Creek project in eastern White Pine County, Nevada, by staking a further 24 claims in the southeast section. The Cherry Creek asset comprises 293 unpatented and patented claims as well as mill rights and spans over 2,442 hectares. It includes more than 20 past producing mines and the new claims are next to an area of prolific historic gold and silver mining, said the company.
Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) has closed on the $1,018,000 purchase of cannabis-processing equipment and leasehold improvements from CMAX Technologies Inc in Ontario. In a statement Tuesday, Canntab said the purchase price was based upon third-party valuations it had ordered. The purchase price was satisfied through the issuance of 1,996,078 common shares of the company at $0.51 each. A deposit of 200,000 shares was paid to CMAX shortly after the execution of the asset purchase agreement.
Medallion Resources Ltd (CVE:MDL) (OTCQB:MLLOF) has revealed that its shares are now changing hands on the OTCQB venture market in New York, increasing the group's access to US-based retail and institutional investors. It comes after the OTC Markets approved the move, which, the firm said, aligns well with Medallion’s focus on production of rare-earth elements (REE) within North America. "While the TSX Venture Exchange remains Medallion’s primary capital market, our leading position in the REE industry, and the importance of REEs to U.S. industry and defense makes the OTCQB Venture Market a natural fit,” said the group's CEO Mark Saxon in a statement.
American Manganese Inc. (CVE:AMY) (OTCPINK:AMYZF) (FRA:2AM) has announced that the company will be extending the exercise period of a total of 1,378,666 share purchase warrants, all of which are exercisable at $0.25 per share. The warrants were issued under a private placement which closed over two tranches in 2017, and the expiry dates for the outstanding warrants had been extended previously by one year. The company proposes to extend the expiry dates for all warrants by another year, and accordingly, the new expiry dates for the warrants are as follows: Tranche 1: For warrants issued on November 1, 2017, the new expiration date of those warrants will be November 1, 2021; Tranche 2: For warrants issued on December 1, 2017, the new expiration date of those warrants will be December 1, 2021. All other terms and conditions of the warrants remain unchanged. The warrant extension is subject to acceptance by the TSX Venture Exchange.
Metalla Royalty and Streaming Ltd (CVE:MTA) said the TSX Venture Exchange has accepted for filing documentation relating to a sale and purchase agreement dated September 17, 2020, between it and vendor Morgan Stanley Capital Group Inc., whereby the company has acquired an existing 27.5% price participation royalty interest on Karora Resources Inc.'s operating Higginsville gold mine, located in Western Australia. Under the terms of the agreement, the US$6.5 million purchase price was satisfied via the issuance of 828,331 common shares at a deemed value of US$7.847 per share.
KULR Technology Group, Inc. (OTCQB:KULR) has said its CEO, Michael Mo, has been invited to present at 'Building the Electric Vehicle Future' Webinar, presented by Maxim Group LLC and M-Vest, on Thursday October 22, 2020, at 11.00am. Eastern time (8.00am Pacific time). Mo will participate in a panel discussion led by Maxim senior research analyst Tate Sullivan, along with other important voices in the electric vehicle industry. Daily developments in the electric vehicle industry suggest many companies may benefit from long-term adoption. EV executives will discuss how their companies can benefit from long-term growth in this industry. To access the conference, investors can click here: https://m-vest.com/insights/marketpulse/rsvp-building-the-electric-vehicle-future?utm_source=newsletter&utm_medium=network&utm_campaign=electric-vehicle-webinar&utm_term=kurl
VolitionRx Limited (NYSEAMERICAN:VNRX), a multi-national epigenetics company developing simple, easy to use, cost-effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, said it hosted a virtual capital markets day event on Tuesday, October 20, 2020, which started at 8.00am Eastern Time. Cameron Reynolds, the group's president and chief executive officer hosted the live-streamed event along with other members of the executive management team. The presentation will focus on new data, and the launch and commercial roll-out of the company's first product, the Nu.Q Vet Cancer Screening Test, which is on target for a launch this year, and will also provide an update on recent developments and Volition's activities, including new and ongoing clinical trials. A recording of the event will be posted to the Volition website on Wednesday, October 21.
CytoDyn Inc. said that Nader Pourhassan, its president and chief executive officer, Scott Kelly, its chairman, chief medical officer and head of Business Development, and Jacob Lalezari, its senior science advisor, will host an investment community webcast on Tuesday, October 20, 2020, at a new time of 2.00pm PT / 5.00pm ET, which is one hour later than the previously announced time. The webcast can also be accessed via the following link: https://78449.themediaframe.com/dataconf/productusers/cydy/mediaframe/41443/indexl.html. The replay will be available approximately 60 minutes after the conclusion of the webcast and can be accessed via the above link until November 20, 2020.
OTC Markets Group Inc. (OTCQX:OTCM), the operator of financial markets for 11,000 US and global securities, has announced that GT Gold Corp. (CVE:GTT) (OTCQX:GTGDF), a company focused on exploring for base and precious metals in British Columbia's Golden Triangle, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTC Pink market. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the US. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. "We are very pleased to be upgrading to the OTCQX Market," said Paul Harbidge, president and chief executive officer of GT Gold Corp. "We look forward to expanding our disclosure and visibility to connect with new investors across the US and to share GT Gold's exciting new gold and copper discoveries in Canada," he added.
TSX Venture Exchange says Canada Silver Cobalt Works Inc (CVE:CCW) (OTCMKTS:CCWOF), in accordance with Policy 2.5, has met the requirements for a Tier 1 company. Therefore, effective October 22, the company's tier classification will change from Tier 2 to Tier 1.
Calyxt Inc (NASDAQ: CLXT), a plant-based technology company, has announced the closing of its previously announced registered direct offering of 3,750,000 shares of the Company’s common stock, at a purchase price of $4 per share. Cellectis SA, the company’s majority shareholder, purchased 1,250,000 shares in the offering. The gross proceeds from the offering were $15 million. Calyxt intends to use the net proceeds for general corporate purposes, including to advance its current product development pipeline and its TALEN technology.